Biomedix

Biomedix is a Biotechnology, Health Care startup founded in 1997 and headquartered in the United States. The company's slogan, "Biomedix is a provider of front-line diagnostic solutions for delivering value-based care," reflects its core mission. Biomedix offers a mobile health assessment platform that centralizes data for analyzing population health across multiple chronic conditions and supports various diagnostic devices. The company is renowned for its flagship product, PADnet, which is the market leader in front-line diagnostics for peripheral vascular disease. This unique device supports the identification of peripheral artery disease (PAD) and chronic venous insufficiency (CVI) through a collaborative care model, enabling cost-effective delivery of care that optimizes patient outcomes. The company's last investment was a $682.24K debt financing investment on 23 November 2012, with undisclosed investors. Biomedix's innovative approach to value-based care and its market-leading diagnostic solutions position it as an attractive investment opportunity in the rapidly evolving landscape of healthcare technology.